Search results
Results from the WOW.Com Content Network
BSE is a transmissible disease that primarily affects the central nervous system; it is a form of transmissible spongiform encephalopathy, like Creutzfeldt–Jakob disease and kuru in humans, scrapie in sheep, and chronic wasting disease in deer.
BSE Limited, also known as the Bombay Stock Exchange (BSE), is an Indian stock exchange with highest number of companies (5,246 (as of 8th February 2022)) which is located on Dalal Street. [8] Established with the efforts of cotton merchant Premchand Roychand in 1875, [ 9 ] [ 10 ] it is the oldest stock exchange in Asia , [ 11 ] and also the ...
BSE is a degenerative infection of the central nervous system in cattle. It is a fatal disease, similar to scrapie in sheep and goats, caused by a prion.A major epizootic affected the UK, and to a lesser extent a number of other countries, between 1986 and the 2000s, infecting more than 190,000 animals, not counting those that remained undiagnosed.
The trading platform of ISE enables the 'Indian companies' to access equity capital, by providing a liquid and well-regulated market. [14] Scrips which are already being traded on stock exchanges across India are traded on the Exchange. ISE's trading members in India trade on the scrips and provide liquidity and visibility to such scrips.
Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks » 1. Amazon Few companies enjoy as strong of a competitive moat as Amazon (NASDAQ: AMZN).
Chart of S&P BSE SENSEX monthly data from January 1991 to May 2013. The following is a timeline on the rise of the SENSEX through Indian stock market history. 1000, 25 July 1990 – On 25 July 1990, the SENSEX touched the four-digit figure for the first time and closed at 1,001 in the wake of a good monsoon and excellent corporate results.
Badla was an indigenous carry-forward system invented on the Bombay Stock Exchange as a solution to the perpetual lack of liquidity in the secondary market. Badla were banned by the Securities and Exchange Board of India (SEBI) in 1993, effective March 1994, amid complaints from foreign investors, with the expectation that it would be replaced by a futures-and-options exchange. [1]
On Friday, Vir Biotechnology, Inc. (NASDAQ:VIR) announced end-of-treatment data from Part B of the MARCH Phase 2 study evaluating combinations of tobevibart and elebsiran, with or without ...